Literature DB >> 2186489

Hepatic fibrosis caused by alcohol.

J J Maher1.   

Abstract

The past decade of research has brought us closer to an understanding of the mechanisms whereby alcohol promotes fibrosis in liver. The perivenular and perisinusoidal fibrosis that characterizes alcoholic cirrhosis suggests that it is a unique entity, distinct from other types of fibrotic liver disease. On a cellular level, though, the target population and the regulatory events that control fibrogenesis may be typical of all types of fibrotic liver disease. The putative pathways to alcoholic fibrosis are exemplified in Figure 1. Fibrosis can be either the direct result of a stimulus from ethanol or one of its metabolites to a target cell population, presumably the lipocytes, or it can begin indirectly in response to hepatic inflammation. The indirect pathway to hepatic fibrosis is likely to be initiated by cytokines, elaborated by inflammatory cells. In addition, invasion of the liver by inflammatory cells may disrupt the normal hepatic extracellular matrix, which may in itself act as a stimulus for fibrogenesis by altering critical cell-matrix interactions. If alteration of the normal hepatic matrix is sufficient to promote fibrogenesis, it may act as a fixed stimulus that perpetuates fibrogenesis in the absence of ongoing inflammation. This may explain the progression of alcoholic fibrosis in some patients in the apparent absence of alcoholic hepatitis. It has been gratifying to observe a consensus emerge among experimental observations regarding the process of alcoholic fibrosis. In particular, the discovery of transitional cells in fibrotic liver tissue, and their relationship to lipocytes, correlates well with studies documenting activation of lipocytes in culture to a fibrogenic phenotype.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2186489     DOI: 10.1055/s-2008-1040458

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

1.  Confluent hepatic fibrosis in liver cirrhosis: possible relation with middle hepatic venous drainage.

Authors:  Kumi Ozaki; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Tetsuya Minami
Journal:  Jpn J Radiol       Date:  2013-06-06       Impact factor: 2.374

2.  Alcoholic liver disease. Parenchyma to stroma relationship in fibrosis and cirrhosis as revealed by three-dimensional reconstruction and immunohistochemistry.

Authors:  H P Dinges; K Zatloukal; H Denk; J Smolle; S Mair
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease.

Authors:  Victoria M Rimkunas; Mark J Graham; Rosanne M Crooke; Laura Liscum
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 4.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Morphometric changes in liver cirrhosis: aetiological differences correlated with progression.

Authors:  Kumi Ozaki; Osamu Matsui; Satoshi Kobayashi; Tetsuya Minami; Azusa Kitao; Toshifumi Gabata
Journal:  Br J Radiol       Date:  2016-01-14       Impact factor: 3.039

Review 6.  Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics.

Authors:  Kumi Ozaki; Kazuto Kozaka; Yasuo Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-28       Impact factor: 2.374

7.  Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Michael F Sorrell; Thomas L Freeman; Dean J Tuma; Lynell W Klassen
Journal:  Comp Hepatol       Date:  2004-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.